1.
Mol Cancer Ther
; 23(5): 619-626, 2024 May 02.
Article
in English
| MEDLINE
| ID: mdl-38693903
Subject(s)
Agammaglobulinaemia Tyrosine Kinase , Humans , Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase/metabolism , B-Lymphocytes/metabolism , Leukemia, B-Cell/metabolism , Leukemia, B-Cell/pathology , Leukemia, B-Cell/drug therapy , Leukemia, B-Cell/genetics , Lymphoma, B-Cell/metabolism , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/drug therapy , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , Protein-Tyrosine Kinases/metabolism , Protein-Tyrosine Kinases/genetics , Proteolysis
2.
Circulation
; 149(10): 790-793, 2024 03 05.
Article
in English
| MEDLINE
| ID: mdl-38437482